Evaluation of renal protection by irbesartan and losartan in renal transplanted patients
Phase 4
- Conditions
- renal transplantation
- Registration Number
- JPRN-UMIN000003359
- Lead Sponsor
- Kanazawa Medical University School of Medicine, Division of Nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Not provided
Exclusion Criteria
renal failure (serum creatinine more than 2.5mg/dL) Child bearing women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method alteration rate of eGFR serum cretinine levels
- Secondary Outcome Measures
Name Time Method clinic blood pressure urinary MCP-1 albuminuria